Skip to Main Content

Paper Details

Antiviral protection by antibodies targeting the glycan cap of Ebola virus glycoprotein requires activation of the complement system.
Res Sq
0
2023
C3, CDC, EBOV, EBOV GP, EBOV infection, Ebola virus, Ebola virus glycoprotein, Fc, GC, GP, GP-expressing cell line, MPER, cobra venom factor, monoclonal, mouse, viral sole glycoprotein GP
Author NameAffiliation
Bronwyn M GunnWashington State University.
Natalia A KuzminaUniversity of Texas Medical Branch.
Pavlo GilchukVanderbilt University Medical Center.
Galit AlterThe Ragon Institute of MGH
James E CroweVanderbilt University Medical Center.
  • 1 - 5

Datasets

Release 1.2